With the ASCO conference on the horizon, pancreatic cancer is emerging as a focal point for researchers and clinicians alike.
Recent advancements in biotechnology, such as promising results from GSK's hepatitis B treatment, are also capturing interest.
The conference is expected to highlight various innovative approaches in cancer treatment, which could influence future research directions.